Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on October 25, 2010, reporting events occurring on October 21, 2010. Lexaria Bioscience Corp. (Lexaria Corp.) is a Nevada corporation headquartered in Vancouver, British Columbia. The filing discloses the entry into a material definitive agreement and the creation of a direct financial obligation related to capital raising activities.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of a new capital raising agreement.
Material Changes and Agreements
On October 21, 2010, the Company entered into a twelve-month non-exclusive capital raising agreement with CC Natural Resource Partners (the "Consultant"). Key terms include:
- Transaction Fee: The Company shall pay the Consultant a fee equal to 5% of the loan or investment amount at the time of closing.
- Fee Cap: If the Consultant demands an additional fee as a condition of the transaction, the combined transaction fee and finder's fee shall not exceed 10% of the transaction value.
- Tail Period: For 24 months following the termination of the agreement, the Company must pay fees for any transactions involving contacts introduced by the Consultant during the agreement term.
- Securities Status: Securities offered under this arrangement will not be registered under the Securities Act of 1933 and may not be sold in the United States absent registration or an applicable exemption.
Outlook, Risks, and Management Commentary
The Company intends to raise capital with the assistance of the Consultant. The filing highlights regulatory risks regarding the sale of unregistered securities in the United States. No specific financial guidance or management commentary on operational performance is provided in this report.
Investor Verification Checklist
- Verify the current status of the capital raising efforts initiated under this agreement.
- Confirm whether any transactions have closed resulting in the 5% or 10% fee obligations.
- Review subsequent filings to determine if the Company secured the intended financing.
- Check for any updates regarding the 24-month tail period obligations post-termination.